论文部分内容阅读
在糖尿病患者中,有一类糖尿病合并妊振的患者,本文将以临床治疗提供的相关依据来进行分析采用胰岛素泵持续皮下注射治疗是否对新生儿产生影响。采用的方法是选取妊娠期糖尿病患者100例,我们根据这些病例入院的时间编号进行了分组,将单号列为对照组,双号列为实验组,各占50例,遵循患者知情同意原则,实验组的患者将进行胰岛素泵持续皮下注射,对照组的患者将进行胰岛素多次皮下注射。结果显示:实验组新生儿低血糖及大于胎龄儿发生率低,且分娩孕周更接近预产期。结论:胰岛素泵持续皮下注射的治疗效果显著,是一种有效地治疗方式,适合临床应用及推广。
In diabetic patients, there is a group of patients with diabetes mellitus and pregnancy-induced vibration. Based on the relevant data provided by clinical treatment, this article will analyze whether continuous subcutaneous injection with insulin pump will affect newborns. The method used was to select 100 patients with gestational diabetes mellitus, we group these patients according to the time of admission numbers, the single number as the control group, double as the experimental group, each 50 cases, follow the principle of informed consent of patients, Patients in the experimental group will be given continuous subcutaneous injections of insulin pumps, and patients in the control group will be given multiple subcutaneous injections of insulin. The results showed that the incidence of hypoglycemia and more than gestational age in the experimental group was low, and the gestational age of delivery was closer to the expected date of birth. Conclusion: The continuous subcutaneous injection of insulin pump has a significant therapeutic effect. It is an effective treatment and is suitable for clinical application and promotion.